Embracing heterogeneity creates new opportunities for understanding and treating those at clinical-high risk for psychosis

Schizophr Res. 2021 Jan:227:1-3. doi: 10.1016/j.schres.2020.11.015. Epub 2020 Dec 4.

Authors

Vijay A Mittal¹, Jean M Addington²

Affiliations

¹ Departments of Psychology, Psychiatry, and Medical Social Sciences, Institutes for Policy Research (IPR) and Innovations in Developmental Sciences (DevSci), Northwestern University, USA. Electronic address: Vijay.mittal@northestern.edu.
² Hotchkiss Brain Institute, Department of Psychiatry University of Calgary, Canada.

PMID: 33288356
DOI: 10.1016/j.schres.2020.11.015

No abstract available

Keywords: Clinical high-risk; Harmonization; Heterogeniety; Outcomes; Prodrome; Treatment development.

Publication types

Editorial

MeSH terms

Humans
Prodromal Symptoms
Psychotic Disorders* / therapy